Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
276.00    11.00 (4.15%)
Bid:
268.00
Ask:
272.00
Spread: 4.00 (1.493%)
Market Cap: £247.17m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Acquisition

27 Nov 2007 07:01

Wilmington Group Plc27 November 2007 27 November 2007 WILMINGTON GROUP PLC WILMINGTON ACQUIRES MATCHETT Wilmington Group plc ("Wilmington") is pleased to announce the acquisition of amajority stake in The Matchett Group Limited ('Matchett'), a professionaltraining business that was previously owned by Alastair Matchett and others. Matchett provides training to professional markets, with a particular emphasison annual graduate induction courses for the major banks both in the UK and US.Alastair Matchett, aged 38, the Managing Director who is highly regarded withinthe financial sector will retain a significant equity interest in Matchett as heleads its development within CLT Group. The acquisition of Matchett has been effected by Wilmington's wholly ownedsubsidiary CLT Group, which has acquired 80% of the fully diluted share capitalfor an initial cash consideration of £5.7m and repayment of existing debt of£3.9m. Wilmington will fund the consideration from existing debt facilities.Further consideration is payable in respect of the 80% stake dependent onprofits during the year to 31 December 2008. The aggregate amount payable forthe 80% stake, comprising the further consideration together with the initialconsideration and repayment of debt, is capped at £15m. The transaction isexpected to be earnings enhancing in the first full year of ownership. Put and call options have been entered into by CLT Group whereby the 20%shareholders of Matchett can require CLT Group to acquire their shares for aconsideration based on a formula linked to future profits. Similarly from 2015,CLT Group can require any remaining minority shareholders to sell their sharesto CLT Group, again based on a formula linked to profits. The amount payableunder the arrangements is capped at £21m (including the initial and deferredconsideration and debt repayments). During the year ended 31 December 2006, the period of the latest auditedaccounts, Matchett made profits before interest, tax and amortisation of £1.2mon turnover of £7.1m. At 31 December 2006, it had audited gross assets of £8.3m. Charles Brady, CEO of Wilmington, commented "Matchett Group will provide a natural fit with both the market place andproducts of CLT Group, thus allowing us to exploit direct synergies between theexisting CLT Group and Matchett. We are already seeing the results of the substantial investments in regulatoryand compliance training that we have made, with major contracts being awarded toCLT Group, most recently from the Singapore Government. The acquisition ofMatchett will enhance the product range of the group and enable us to provide awider range of support to existing and new clients, while creating opportunitiesin a wider range of jurisdictions". Ends Enquiries: Wilmington Group plcCharles Brady, Chief Executive 020 7422 6800 Weber Shandwick FinancialNick Oborne/Georgia Dempsey/Charlie Hooper 020 7067 0700 Notes to Editors Wilmington Group plc is one of the UK's leading providers of information andtraining for professional business markets. The Group provides training,arranges industry events and publishes magazines, directories, databases andspecial reports focused primarily on its two principal sectors of Legal &Regulatory, and Business Information which comprises Healthcare and Mediabusinesses. Capitalised at approximately £185 million, Wilmington floated on theLondon Stock Exchange in 1995. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.